BeyondSpring, Inc. (BYSI)
NCM · Common · CUSIP G10830100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BYSI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G10830100
Market Cap
Small Cap
IPO
3/8/2017 · $20.00/share
Business: BeyondSpring, Inc. is a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, including late stage immuno-oncology agents. The Company was established in 2013 and is headquartered in the United States. Its lead asset, Plinabulin, is derived from a natural compound and has a number of biochemical activities providing multiple potential therapeutic potentials in a variety of cancers.

Company Contact

CEO
Lan Huang
CFO
Elizabeth Czerepak
Headquarters
100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, NJ 07932
Phone
646-305-6387
Fax
646-219-9660
Investor Relations
Ashley R. Robinson, LifeSci Partners · 617-430-7577 · arr@lifesciadvisors.com
SEC EDGAR Filings
View filings »